These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18643911)

  • 21. Towards minimizing immunosuppression in pediatric liver transplant recipients.
    Turmelle YP; Nadler ML; Anderson CD; Doyle MB; Lowell JA; Shepherd RW
    Pediatr Transplant; 2009 Aug; 13(5):553-9. PubMed ID: 19067920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
    Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J
    Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry.
    Melzi ML; Kelly DA; Colombo C; Jara P; Manzanares J; Colledan M; Strazzabosco M; DeLorenzo P; Valsecchi MG; Adam R; Gridelli B; Assael BM; ; ;
    Transpl Int; 2006 Sep; 19(9):726-31. PubMed ID: 16918533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a north american multicenter registry.
    Ng VL; Fecteau A; Shepherd R; Magee J; Bucuvalas J; Alonso E; McDiarmid S; Cohen G; Anand R;
    Pediatrics; 2008 Dec; 122(6):e1128-35. PubMed ID: 19047213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal function in pediatric liver transplantation: a long-term follow-up study.
    Harambat J; Ranchin B; Dubourg L; Liutkus A; Hadj-Haïssa A; Rivet C; Boillot O; Lachaux A; Cochat P
    Transplantation; 2008 Oct; 86(8):1028-34. PubMed ID: 18946339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long-term impact of liver transplantation on kidney function in familial amyloidotic polyneuropathy patients.
    Nowak G; Suhr OB; Wikström L; Wilczek H; Ericzon BG
    Transpl Int; 2005 Jan; 18(1):111-5. PubMed ID: 15612992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperuricemia after liver transplantation in children.
    Harambat J; Dubourg L; Ranchin B; Hadj-Aïssa A; Fargue S; Rivet C; Boillot O; Lachaux A; Cochat P
    Pediatr Transplant; 2008 Dec; 12(8):847-53. PubMed ID: 18537903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-transplant diabetes mellitus in pediatric liver transplantation.
    Hathout E; Alonso E; Anand R; Martz K; Imseis E; Johnston J; Lopez J; Chinnock R; McDiarmid S;
    Pediatr Transplant; 2009 Aug; 13(5):599-605. PubMed ID: 18179639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical correlation between dyslipidemia and pediatric chronic allograft nephropathy.
    Valavi E; Otukesh H; Fereshtehnejad SM; Sharifian M
    Pediatr Transplant; 2008 Nov; 12(7):748-54. PubMed ID: 18503482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperlipidemia after renal transplantation and its relation to graft and patient survival.
    Ramezani M; Einollahi B; Ahmadzad-Asl M; Nafar M; Pourfarziani V; Samadpour A; Moradi M; Alghasi M; Chalian H; Davoudi F
    Transplant Proc; 2007 May; 39(4):1044-7. PubMed ID: 17524887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.
    Tory R; Sachs-Barrable K; Goshko CB; Hill JS; Wasan KM
    Transplantation; 2009 Jul; 88(1):62-8. PubMed ID: 19584682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in invasive disease due to Candida species following heart and lung transplantation.
    Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
    Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the CC chemokine receptor 5Delta32 polymorphism in pediatric liver transplant recipients.
    Fischer-Maas L; Schneppenheim R; Oyen F; Grabhorn E; Richter A; Fischer L; Ganschow R
    Pediatr Transplant; 2008 Nov; 12(7):769-72. PubMed ID: 18194353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ezetimibe in the treatment of uncontrolled hyperlipidemia in kidney transplant patients.
    Rodríguez-Ferrero ML; Anaya F
    Transplant Proc; 2008 Dec; 40(10):3492-5. PubMed ID: 19100421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pediatric liver transplantation in 20 consecutive children].
    Shen ZY; Zhu ZJ; Zang YJ; Zheng H; Deng YL; Pan C; Chen XG; Wang ZF; Zheng WP
    Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):173-5. PubMed ID: 18683710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ezetimibe treatment of pediatric patients with hypercholesterolemia.
    Clauss S; Wai KM; Kavey RE; Kuehl K
    J Pediatr; 2009 Jun; 154(6):869-72. PubMed ID: 19230898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive activity of serum taken from a liver transplant recipient after withdrawal of immunosuppressants.
    Hsu LW; Goto S; Nakano T; Lai CY; Lin YC; Kao YH; Chen SH; Cheng YF; Jawan B; Chiu KW; Chen CL
    Transpl Immunol; 2007 Feb; 17(2):137-46. PubMed ID: 17306745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation in children with hepatocellular carcinoma. Do Milan criteria apply to pediatric patients?
    Ismail H; Broniszczak D; Kaliciński P; Markiewicz-Kijewska M; Teisseyre J; Stefanowicz M; Szymczak M; Dembowska-Bagińska B; Kluge P; Perek D; Kościesza A; Dzik E; Lembas A; Teisserye M
    Pediatr Transplant; 2009 Sep; 13(6):682-92. PubMed ID: 19496985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
    Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M
    Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients.
    Pons JA; Ramírez P; Revilla-Nuin B; Pascual D; Baroja-Mazo A; Robles R; Sanchez-Bueno F; Martinez L; Parrilla P
    Clin Transplant; 2009; 23(3):329-36. PubMed ID: 19210687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.